Acquisition of Bioline Group (Details 2) (USD $) In Thousands, except Per Share data	3 Months Ended	9 Months Ended
Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Consolidated pro forma results of the combined entities
Net Sales	$ 40,052	$ 37,361	$ 118,374	$ 117,208
Net Earnings	$ 6,857	$ 7,201	$ 20,565	$ 20,757
Diluted Earnings Per Common Share	$ 0.17	$ 0.17	$ 0.50	$ 0.50

The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 68
-Subparagraph r(2, 3)

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 54

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 55

+ Details

Name:	us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted
Namespace Prefix:	us-gaap
Data Type:	us-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_BusinessAcquisitionProFormaInformationAbstract
Namespace Prefix:	us-gaap
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The pro forma net income (loss) for the period as if the business combination or combinations had been completed at the beginning of a period

+ References

+ Details

Name:	us-gaap_BusinessAcquisitionProFormaNetIncomeLoss
Namespace Prefix:	us-gaap
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period

+ References

+ Details

Name:	us-gaap_BusinessAcquisitionProFormaRevenue
Namespace Prefix:	us-gaap
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration